INFORMATIONAL PURPOSES ONLY. Not medical, legal, or travel advice. Verify with official sources before acting. See corrections log.
Regenerative medicine laws and requirements in Tennessee. Citations, verification dates, and source links for every data point.
| Dimension | Value | Citation | Source | Verified | Confidence |
|---|---|---|---|---|---|
| Permit Unapproved Cell Therapies | permit cell therapies | 2026 Tenn. Pub. Acts ch. 1016, § 1(b)“A physician may perform stem cell therapy or regenerative medicine therapy that is not approved by the United States food and drug administration if the therapy is used for a treatment or procedure”Note: Enacted 2026 (HB 2246, Pub. Ch. 1016; bill history: 'Signed by Governor', effective dates 05/19/2026 (rulemaking) and 07/01/2026). Codified section number within Title 63, Ch. 6, Part 2 not confirmed. Does not apply to hospitals/affiliated outpatient clinics, FDA IND therapy, or Right to Try therapy. | Link | 2026-10-09 | high |
| Require Patient Disclosure for Cell Therapies | require disclosure | 2026 Tenn. Pub. Acts ch. 1016, § 1(d)-(e)“Before performing stem cell therapy or regenerative medicine therapy under this section, a physician must obtain a written consent form signed by the patient”Note: Also requires a statutory notice ('THIS NOTICE MUST BE PROVIDED TO YOU UNDER TENNESSEE LAW...') in each advertisement. Enacted 2026 (HB 2246, Pub. Ch. 1016; bill history: 'Signed by Governor', effective dates 05/19/2026 (rulemaking) and 07/01/2026). Codified section number within Title 63, Ch. 6, Part 2 not confirmed. Does not apply to hospitals/affiliated outpatient clinics, FDA IND therapy, or Right to Try therapy. | Link | 2026-10-09 | high |
| Limit Practitioner Scope for Cell Therapies | Physicians (licensed under Tenn. Code Ann. title 63, chapter 6 or 9, i.e. MD or DO), for treatments within the physician's scope of practice; products must come from compliant facilities. | 2026 Tenn. Pub. Acts ch. 1016, § 1(a)(2), (b)-(c)“"Physician" means a person licensed pursuant to chapter 6 or 9 of this title”Note: Quote taken from House Amendment 1 (HA0940), whose text matches the enacted Public Chapter (pc1016.pdf scan has the same definition). Enacted 2026 (HB 2246, Pub. Ch. 1016; bill history: 'Signed by Governor', effective dates 05/19/2026 (rulemaking) and 07/01/2026). Codified section number within Title 63, Ch. 6, Part 2 not confirmed. Does not apply to hospitals/affiliated outpatient clinics, FDA IND therapy, or Right to Try therapy. | Link | 2026-10-09 | high |
| Have Cell Therapy Statute References | 2026 Tenn. Pub. Acts ch. 1016 (HB 2246), new section in Tenn. Code Ann. Title 63, Chapter 6, Part 2; effective July 1, 2026 | Tennessee Public Chapter No. 1016 (2026)“SECTION 1. Tennessee Code Annotated, Title 63, Chapter 6, Part 2, is amended by adding the following as a new section:”Note: Enacted 2026 (HB 2246, Pub. Ch. 1016; bill history: 'Signed by Governor', effective dates 05/19/2026 (rulemaking) and 07/01/2026). Codified section number within Title 63, Ch. 6, Part 2 not confirmed. Does not apply to hospitals/affiliated outpatient clinics, FDA IND therapy, or Right to Try therapy. | Link | 2026-10-09 | high |
View full Tennessee profile (all layers) · Report an error on this page